| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |